GP
GREAT POINT PARTNERS LLC
Greenwich CT · SEC CIK 0001281446
$529.12M2026Q2 reported value
42Positions
51.6%Top 10 weight · largest 10.1%
10 / 12New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
ABVX New+$27.23M
DFTX New+$19.99M
VERA Added+$17.23M
SGMT New+$15.69M
IMMX Added+$9.56M
2026Q2 top sells estimated at quarter-end value
APOGEE THERAPEUT Sold out-$31.48M
AMLX Reduced-$18.86M
KALVISTA PHARMAC Sold out-$13.59M
IMVT Sold out-$13.55M
JBIO Sold out-$13.55M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA Call | $53.30M | 10.07% | 400,000 | 400,000 | — | $53.30M | New |
| VOR | VOR BIOPHARMA INC | $31.30M | 5.91% | 1,700,000 | -50,000 | -2.9% | -$920,500 | Reduced |
| ABVX | ABIVAX SA | $27.23M | 5.15% | 204,314 | 204,314 | — | $27.23M | New |
| IBRX | IMMUNITYBIO INC Put | $26.27M | 4.97% | 3,000,800 | 0 | 0.0% | — | Unchanged |
| VERA | VERA THERAPEUTICS INC | $25.78M | 4.87% | 600,836 | 401,488 | 201.4% | $17.23M | Added |
| ZURA | ZURA BIO LTD | $24.87M | 4.70% | 4,215,930 | 0 | 0.0% | — | Unchanged |
| ALMS | ALUMIS INC | $24.09M | 4.55% | 856,061 | 0 | 0.0% | — | Unchanged |
| — | SOL-GEL TECHNOLOGIES LTD | $20.34M | 3.84% | 274,363 | 0 | 0.0% | — | Unchanged |
| RARE | ULTRAGENYX PHARMACEUTICAL IN Put | $20.03M | 3.79% | 600,000 | 600,000 | — | $20.03M | New |
| DFTX | DEFINIUM THERAPEUTICS INC | $19.99M | 3.78% | 425,000 | 425,000 | — | $19.99M | New |
| ANNX | ANNEXON INC | $19.98M | 3.78% | 3,500,000 | 1,000,000 | 40.0% | $5.71M | Added |
| ORKA | ORUKA THERAPEUTICS INC | $17.45M | 3.30% | 183,330 | 0 | 0.0% | — | Unchanged |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $16.66M | 3.15% | 855,813 | 355,813 | 71.2% | $6.93M | Added |
| SGMT | SAGIMET BIOSCIENCES INC | $15.69M | 2.97% | 2,029,933 | 2,029,933 | — | $15.69M | New |
| CTNM | CONTINEUM THERAPEUTICS INC | $15.10M | 2.85% | 921,481 | 121,283 | 15.2% | $1.99M | Added |
| IMMX | IMMIX BIOPHARMA INC | $13.17M | 2.49% | 1,277,642 | 927,642 | 265.0% | $9.56M | Added |
| CLYM | CLIMB BIO INC | $13.04M | 2.46% | 1,000,000 | -334,130 | -25.0% | -$4.36M | Reduced |
| AMLX | AMYLYX PHARMACEUTICALS INC | $12.57M | 2.38% | 700,000 | -1,050,000 | -60.0% | -$18.86M | Reduced |
| NKTR | NEKTAR THERAPEUTICS | $12.22M | 2.31% | 175,000 | -141,453 | -44.7% | -$9.87M | Reduced |
| NGNE | NEUROGENE INC | $11.08M | 2.09% | 352,180 | -147,820 | -29.6% | -$4.65M | Reduced |
| LBRX | LB PHARMACEUTICALS INC | $10.30M | 1.95% | 317,221 | 17,221 | 5.7% | $558,908 | Added |
| IRD | OPUS GENETICS INC | $8.10M | 1.53% | 1,970,187 | 1,645,847 | 507.4% | $6.76M | Added |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | $7.93M | 1.50% | 1,200,000 | 0 | 0.0% | — | Unchanged |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | $7.69M | 1.45% | 109,603 | -110,397 | -50.2% | -$7.75M | Reduced |
| IFRX | INFLARX NV | $6.82M | 1.29% | 3,046,557 | 3,046,557 | — | $6.82M | New |
| RLMD | RELMADA THERAPEUTICS INC | $5.83M | 1.10% | 842,106 | 0 | 0.0% | — | Unchanged |
| — | JATT II ACQUISITION CORP | $5.68M | 1.07% | 500,000 | 500,000 | — | — | First reported |
| CGEM | CULLINAN THERAPEUTICS INC | $5.46M | 1.03% | 300,000 | 0 | 0.0% | — | Unchanged |
| ALT | ALTIMMUNE INC | $5.29M | 1.00% | 1,741,232 | 1,741,232 | — | $5.29M | New |
| — | AMANAT ACQUISITION CORP | $5.08M | 0.96% | 500,000 | 500,000 | — | — | First reported |
| RZLT | REZOLUTE INC | $4.95M | 0.94% | 951,809 | 0 | 0.0% | — | Unchanged |
| SLN | SILENCE THERAPEUTICS PLC | $4.94M | 0.93% | 450,000 | -570,489 | -55.9% | -$6.26M | Reduced |
| PALI | PALISADE BIO INC | $4.78M | 0.90% | 2,284,819 | -1,120,938 | -32.9% | -$2.34M | Reduced |
| EVMN | EVOMMUNE INC | $4.32M | 0.82% | 325,000 | 0 | 0.0% | — | Unchanged |
| — | SCYNEXIS INC | $3.84M | 0.73% | 944,292 | -1 | -0.0% | -$6 | Reduced |
| — | GALECTIN THERAPEUTICS INC Call | $3.71M | 0.70% | 800,000 | 0 | 0.0% | — | Unchanged |
| ELVN | ENLIVEN THERAPEUTICS INC | $3.55M | 0.67% | 70,000 | 70,000 | — | $3.55M | New |
| — | HUMACYTE INC | $2.93M | 0.55% | 3,750,000 | 0 | 0.0% | — | Unchanged |
| — | REIN THERAPEUTICS INC | $2.68M | 0.51% | 2,575,000 | 2,575,000 | — | $2.68M | New |
| DBVT | DBV TECHNOLOGIES S A | $2.57M | 0.49% | 156,906 | 156,906 | — | $2.57M | New |
| — | ANAVEX LIFE SCIENCES CORP Call | $1.35M | 0.26% | 521,300 | 0 | 0.0% | — | Unchanged |
| — | PROMIS NEUROSCIENCES INC | $1.13M | 0.21% | 86,150 | -285,252 | -76.8% | -$3.75M | Reduced |
| — | APOGEE THERAPEUTICS INC | $0 | 0.00% | 0 | -374,000 | -100.0% | -$31.48M | Sold out |
| — | KALVISTA PHARMACEUTICALS INC | $0 | 0.00% | 0 | -675,000 | -100.0% | -$13.59M | Sold out |
| IMVT | IMMUNOVANT INC | $0 | 0.00% | 0 | -545,625 | -100.0% | -$13.55M | Sold out |
| JBIO | JADE BIOSCIENCES INC | $0 | 0.00% | 0 | -964,462 | -100.0% | -$13.55M | Sold out |
| ZBIO | ZENAS BIOPHARMA INC | $0 | 0.00% | 0 | -524,066 | -100.0% | -$10.25M | Sold out |
| CMPX | COMPASS THERAPEUTICS INC | $0 | 0.00% | 0 | -1,350,000 | -100.0% | -$7.14M | Sold out |
| — | CONTEXT THERAPEUTICS INC | $0 | 0.00% | 0 | -2,238,496 | -100.0% | -$5.86M | Sold out |
| — | UNICYCIVE THERAPEUTICS INC | $0 | 0.00% | 0 | -796,558 | -100.0% | -$5.24M | Sold out |
| TENX | TENAX THERAPEUTICS INC | $0 | 0.00% | 0 | -327,307 | -100.0% | -$5.23M | Sold out |
| PHVS | PHARVARIS N V | $0 | 0.00% | 0 | -82,800 | -100.0% | -$2.34M | Sold out |
| AVTX | AVALO THERAPEUTICS INC | $0 | 0.00% | 0 | -124,666 | -100.0% | -$1.86M | Sold out |
| ALKS | ALKERMES PLC | $0 | 0.00% | 0 | -50,000 | -100.0% | -$1.77M | Sold out |